Litcius/Paper detail

IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation

Yohei Iguchi, Yuhei Takahashi, Jiayi Li, Kunihiko Araki, Yoshinobu Amakusa, Yu Kawakami, Kenta Kobayashi, S. Yokoi, Masahisa Katsuno

2024The Journal of Cell Biology17 citationsDOIOpen Access PDF

Abstract

Cytoplasmic aggregation of TDP-43 in neurons is a pathological feature common to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). We demonstrate that the IκB kinase (IKK) complex promotes the degradation of cytoplasmic TDP-43 through proteasomes. While IKKβ is a major factor in TDP-43 degradation, IKKα acts as a cofactor, and NEMO functions as a scaffold for the recruitment of TDP-43 to the IKK complex. Furthermore, we identified IKKβ-induced phosphorylation sites of TDP-43 and found that phosphorylation at Thr8 and Ser92 is important for the reduction of TDP-43 by IKK. TDP-43 phosphorylation at Ser92 was detected in a pattern different from that of C-terminal phosphorylation in the pathological inclusion of ALS. IKKβ was also found to significantly reduce the expression level and toxicity of the disease-causing TDP-43 mutation. Finally, the favorable effect of IKKβ on TDP-43 aggregation was confirmed in the hippocampus of mice. IKK and the N-terminal phosphorylation of TDP-43 are potential therapeutic targets for ALS and FTLD.

Topics & Concepts

PhosphorylationIκB kinaseKinaseAmyotrophic lateral sclerosisFrontotemporal lobar degenerationProteasomeCell biologySubcellular localizationBiologyCancer researchCytoplasmChemistrySignal transductionNF-κBMedicineFrontotemporal dementiaInternal medicineDementiaDiseaseAmyotrophic Lateral Sclerosis ResearchParkinson's Disease Mechanisms and TreatmentsNeurogenetic and Muscular Disorders Research
IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation | Litcius